Article
23 Jun 2026
SPC Manufacturing Waiver
AUTHORS CONTENT
Article
19 Jun 2026
SPCs To Keep The CJEU Busy: Four Referrals To Watch
Article
04 Mar 2026
Review Of EPO Antibody Decisions In 2025
Article
12 Dec 2025
Supplementary Protection Certificates
Article
27 Jun 2025
National Courts Apply The CJEU's "Invention Test" For Combination SPCs – And Differ In Their Application
Article
20 Mar 2025
Review Of EPO Antibody Decisions In 2024
Article
06 Feb 2025
No SPCs In The UK For New Therapeutic Uses – Court Of Appeal Does Not Depart From Santen
Article
27 Dec 2024
CJEU Introduces An "Invention" Test For Combination Products To Be Eligible For SPC Protection
Article
28 Nov 2024
Teva Fined €462.6 Million By European Commission For Abusing EPO's Patent System
Article
21 May 2024
Review Of Recent SPC Case Law In The UK – Little Appetite For Divergence From The EU
Article
16 May 2024
Patenting Antibody Pharmaceuticals At The EPO (Video)
Article
08 May 2024
Review Of EPO Antibody Decisions In 2023
Article
11 Oct 2023
Patent Filing: What To Expect During Patent Prosecution
Article
18 Sep 2023
Update On The Windsor Framework And Its Relevance To SPCs And Paediatric Extensions In The UK
Article
15 Sep 2023
Patent Filing: Validity And Timing Considerations
Article
15 Sep 2023
Why Does My Start-Up Need Patents?
Article
15 Sep 2023
Patent Strategy And Portfolio Building
Article
14 Sep 2023
Orphan Drugs In The EU/EEA And UK
Article
14 Sep 2023
Data Exclusivity And Market Protection In The EU / EEA And UK
Article
14 Sep 2023
Third Party Intellectual Property